With a wealth of experience in high complexity clinical diagnostic
laboratory services, the owner and Principal consultant, Dr. van Wijk
is passionate about improving healthcare through innovative solutions.
He is board-certified by the American Board of Clinical Chemistry, and
by the American Society of Clinical Pathology Board of Certification.
His diverse expertise stems from serving as Senior Medical Director at
Beckman Coulter Diagnostics where he supported medical strategy,
innovation, and new product development & launch, and Assistant
Professor of Pathology at the University of Chicago where he oversaw
the Clinical Chemistry, Mass Spectrometry, Blood Gas, and
Pharmacogenomics Laboratories as an attending clinical chemist. Please
refer to Areas of Expertise section for more information on Dr. van
Wijk’s experience, research, innovation and recent publications.
Dr. van Wijk’s LinkedIn
Dr. van Wijk’s publications
Clinical Diagnostics, Laboratory and Medical/Regulatory Affairs Consulting, CLIA Laboratory Directorship for Moderate- and High-Complexity Laboratories, and Medical Writing Services
Dr. van Wijk is well-versed in working in regulated environments (CLIA/CAP/COLA, FDA) and has validated numerous laboratory-developed tests (LDTs) in for example molecular diagnostics (pharmacogenomics, molecular microbiology) and mass spectrometry (hormones, toxicology, TDM). He has functioned as a high-complexity CLIA laboratory director, technical supervisor and/or clinical consultant for a wide variety of clinical laboratories. He holds multiple board and leadership positions (e.g., ADLM, CLSI) and has a strong track record of scientific contributions with 55+ peer-reviewed articles, book chapters, and podium presentations. He has received several recent major national awards & recognitions, including the prestigious ADLM Academy George Grannis Award.
Keep up to date on the proposed regulatory changes to LDTs with key information sources listed here.